glp 1 agonist statpearls Beyond glycemia: Comparing tirzepatide to GLP-1 analogues | Reviews in Endocrine and Metabolic Disorders The expanding scope of GLP-1
Description
That cross-substance signal points to a shared biology underlying addiction, and it opens the door to a fundamentally different approach: not treating one addiction at a time, but targeting that common biologic signal, that common craving across addictions
doi: 10.1016/j.jacl.2023.10.011
The approach depends on how many days have elapsed since the scheduled injection
Zhu C, Lai Y, Liu C, Teng L, Zhu Y, Lin X, et al
